We demonstrated that OA activates Nrf2 signaling, protecting retinal ganglion cells from ischemic injury, in the rAION model and could potentially be used as a therapeutic approach in ischemic optic neuropathy. This evidence concerns the gene NFE2L2 and anterior ischemic optic neuropathy.